1. Home
  2. IMNM vs HBT Comparison

IMNM vs HBT Comparison

Compare IMNM & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • HBT
  • Stock Information
  • Founded
  • IMNM 2006
  • HBT 1920
  • Country
  • IMNM United States
  • HBT United States
  • Employees
  • IMNM N/A
  • HBT N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • HBT Major Banks
  • Sector
  • IMNM Health Care
  • HBT Finance
  • Exchange
  • IMNM Nasdaq
  • HBT Nasdaq
  • Market Cap
  • IMNM 945.8M
  • HBT 812.0M
  • IPO Year
  • IMNM 2020
  • HBT 2019
  • Fundamental
  • Price
  • IMNM $10.30
  • HBT $26.58
  • Analyst Decision
  • IMNM Strong Buy
  • HBT Buy
  • Analyst Count
  • IMNM 7
  • HBT 5
  • Target Price
  • IMNM $24.57
  • HBT $29.00
  • AVG Volume (30 Days)
  • IMNM 629.1K
  • HBT 32.3K
  • Earning Date
  • IMNM 08-06-2025
  • HBT 10-20-2025
  • Dividend Yield
  • IMNM N/A
  • HBT 3.34%
  • EPS Growth
  • IMNM N/A
  • HBT 8.10
  • EPS
  • IMNM N/A
  • HBT 2.42
  • Revenue
  • IMNM $12,589,000.00
  • HBT $229,851,000.00
  • Revenue This Year
  • IMNM N/A
  • HBT $8.74
  • Revenue Next Year
  • IMNM $154.73
  • HBT $2.25
  • P/E Ratio
  • IMNM N/A
  • HBT $10.38
  • Revenue Growth
  • IMNM 16.74
  • HBT 4.61
  • 52 Week Low
  • IMNM $5.15
  • HBT $19.46
  • 52 Week High
  • IMNM $16.73
  • HBT $26.86
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 53.80
  • HBT 63.91
  • Support Level
  • IMNM $9.37
  • HBT $24.31
  • Resistance Level
  • IMNM $10.39
  • HBT $25.76
  • Average True Range (ATR)
  • IMNM 0.49
  • HBT 0.68
  • MACD
  • IMNM -0.06
  • HBT 0.14
  • Stochastic Oscillator
  • IMNM 52.81
  • HBT 96.22

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About HBT HBT Financial Inc.

HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.

Share on Social Networks: